Electronic Bio Sciences was founded in 2002 to commercialize technology for biological research, pharmaceutical development, and diagnostics.
Our company focus is the development of our core technology, which offers the ability to measure electrical potential in cells without physical insertion of a probe, or otherwise rupturing the cell membrane. Such non-invasive measurement of intact, living cells is a revolutionary concept, with potential applications ranging from basic neuroscience to pharmaceutical screening.
Non-Invasive Readout of the Bioelectric Potential of a Cell
In 2003, Electronic Bio Sciences was awarded a contract from the Defense Advanced Research Projects Agency (DARPA) to investigate the development of sensing technology capable of non-invasively measuring the electrical potential of a living cell. In 2004, follow-on funding for broadening of the research was awarded by DARPA in the amount of 115% of the original award.
Preliminary Analysis of Possible Configurations for Stochastic Sensing Systems In 2005, DARPA awarded Electronic Bio Sciences a contract to investigate configurations for stochastic sensing systems. Stochastic sensing is a molecule level detection process that can identify specific analytes in a mixture and also determine the concentration of those analytes. Current techniques involve rather cumbersome laboratory apparatuses and Electronic Bio Sciences’ research will yield valuable information on how to better leverage this technique to accomplish a wide range of research tasks.
Engineered Biomolecular Nano Devices/Systems
In 2005, Electronic Bio Sciences was selected to receive a $12 million contract under the DARPA program “Engineered Biomolecular Nano Devices/Systems.” The objective of the research to be conducted under this project is exploring innovations that allow the development of interfaces to enable real-time translation of molecular events into electrical signal measurements. The end goal of the work is to use these signal measurements for analysis and detection of molecular targets. Electronic Bio Sciences has assembled a large group of talented collaborators to accomplish this goal. As of June 2008, our collaborators include groups from the University of Utah, University of Texas Arlington, University of Miami, Texas A&M and the Max Planck Institute Mainz.
Electronic Bio Sciences is led by founder Dr. Andrew D. Hibbs, who is also CEO of sister companies Quantum Applied Science & Research (QUASAR), Inc. and QUASAR Federal Systems (QFS), Inc. QUASAR and QFS are world leaders in the development of electromagnetic sensors and systems for applications in the medical, geophysical science and defense industries.
Intellectual Property
Electronic Biosciences has an active IP program, with patent pending on all of our core technology and plans to continue to protect our ideas and products. EBS’s team of professionals has extensive experience in IP portfolio management and we have established a productive relationship with a firm specializing in IP legal services that has offices in close proximity to the USPTO.
